Crescent Biopharma, Inc. (NasdaqCM: CBIO)
Health Care · Biotechnology · US
$14.46
-3.02% today · +45.5% 1Y
Crescent Biopharma, Inc. (NasdaqCM: CBIO) operates in the Biotechnology industry within the Health Care sector. The company is valued at $638.16M and employs 44 people.
Over the last twelve months the share price has gained 45.5%, trading between 8.72 and 27.41.
Tweenvest scores Crescent Biopharma, Inc. across four factors: quality 46/100, value 52/100. Its strongest factor is value.
CBIO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $638.16M
- Revenue (TTM)
- $11.88M
- P/E
- —
- EPS
- -6.03
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $27.41
- 52-week low
- $8.72
- Avg volume (3M)
- —
- Shares outstanding
- 42.80M
- Employees
- 44
- Next earnings
- —
About Crescent Biopharma, Inc.
Crescent Biopharma, Inc. is a biotechnology firm dedicated to the research and development of novel cancer therapies. Its investigational portfolio notably includes CR-001, a proprietary bispecific antibody engineered to simultaneously target PD-1 and VEGF pathways for the treatment of solid tumors. The company's pipeline further comprises CR-002 and CR-003. Crescent Biopharma also maintains a strategic alliance with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., focusing on the joint advancement and commercialization of oncology therapeutics, encompassing innovative combination approaches. The company's operations are headquartered in Waltham, Massachusetts.
- ISIN
- KYG2545C1042
- Founded
- 2024
- Listed since
- Jan 10, 2014
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Faeth Therapeutics, Inc.NasdaqCM: FTH | $672.63M | $23.25 | -10.68% |
| Abbisko Cayman LimitedSEHK: 2256 | $665.94M | HK$7.89 | -9.83% |
| Beijing Bohui Innovation Biotechnology Group Co., Ltd.SZSE: 300318 | $646.39M | CN¥5.30 | +1.34% |
| Prime Medicine, Inc.NasdaqGM: PRME | $642.23M | $3.61 | -9.52% |
| Medigen Vaccine Biologics CorporationTPEX: 6547 | $637.45M | NT$62.00 | +1.97% |
| CK Life Sciences Int'l., (Holdings) Inc.SEHK: 775 | $636.85M | HK$0.52 | -1.89% |
| Elixiron Immunotherapeutics (Cayman) LimitedTPEX: 7871 | $634.12M | NT$151.00 | -1.95% |
| Sagimet Biosciences Inc.NasdaqGM: SGMT | $633.21M | $8.80 | -1.46% |
Figures last refreshed Oct 11, 2026.